Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biovault Technical is a leading human tissue and cell bank based in the United Kingdom, specializing in the processing and cryopreservation of umbilical cord blood, cord tissue, and various human tissues for clinical use. The company operates a state-of-the-art facility that serves both the public health sector, including the NHS, and private clients through its Biovault Family brand. Biovault is highly regulated and holds licenses from the Human Tissue Authority (HTA) and the Medicines and Healthcare products Regulatory Agency (MHRA), ensuring the highest standards for regenerative medicine applications. Their core business involves the recovery, processing, and long-term storage of stem cells and orthopedic tissues such as bone, tendons, and skin. By providing critical infrastructure for cell-based therapies, Biovault supports the treatment of over 80 different diseases, ranging from blood cancers to complex reconstructive surgeries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biovault Technologies.